Japan's Takeda agrees $62 billion takeover of Shire

Takeda Pharma agreed to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) on May 8 after the Japanese company raised the amount of cash in its offer to $30.33 to secure a recommendation.